Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Arbutus Biopharma Corp
ABUS
Core
Clinical Hold
Lead Asset Progress
Indication Expansion
Biotech Risk
Clinical Hold Active
Core
Indication Expansion
Lead Asset Progress
Other
Share Repurchase Activity Disclosed
Merger Proxy Statement Disclosure
Tender Offer Withdrawal Disclosure
Other
Rsu Psu Vesting Schedule Disclosed
Clawback Policy Disclosed
Liquidity Position Snapshot Disclosed
Restructuring Charge Disclosed
Share Withholding Tax Settlement
Checkpoint Inhibitor Program
Nqso Definition Provision
Protocol Amended
Equity Plan Participant Data Authorization
Shares Outstanding Disclosure
Section 409A Compliance Statement
Cash Flow Statement Investing Activities
Interim Data Positive
Quarterly Dividend Declared
Core
Clinical Trial Result
No signals above threshold for this filing.
Other
Equity Plan Board Approval Conditional On Shareholder Vote
Auditor Appointment Ratification
Committee Discretionary Authority Clause
Market Price Definition
Performance Unit Award Establishment
Equity Award Plan Types Enumerated
Nqso Definition Provision
Section 409A Compliance Statement
Transfer And Demand Rights Limitations
Equity Award Non Transferability Clause
Ltip Plan Title Citation
Nyse Listing Disclosure
Stock Option Ten Year Expiration Term
Plan Committee Administration Clause
Equity Plan Amendment Restriction
Other
Liquidity Position Snapshot Disclosed
Fast Track Designation Received
Fast Track Granted
Orphan Status Granted
Restructuring Charge Disclosed
Capital Raising Uncertainty Disclosed
Cash Flow Statement Investing Activities
Shares Outstanding Disclosure
Patient Retention High
Workforce Reduction Restructuring Plan
Core
Regulatory Designation Only
Clinical Trial Result
Indication Expansion
Biotech Risk
Orphan Drug Designation
Healthcare
Utilization Declining Services